WallStreetZenWallStreetZen

NASDAQ: EDIT
Editas Medicine Inc Stock Ownership - Who owns Editas Medicine?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Editas Medicine Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Amy ParisonSVP Chief Financial Officer2026-03-03474$2.02
$957.48Sell
Linda BurklyEVP CHIEF SCIENTIFIC OFFICER2026-03-03749$2.02
$1.51kSell
Gilmore Neil OneillCEO2026-03-035,394$2.02
$10.90kSell
Gilmore Neil OneillCEO2025-12-035,603$2.15
$12.06kSell
Linda BurklyEVP CHIEF SCIENTIFIC OFFICER2025-12-03713$2.15
$1.54kSell
Amy ParisonSVP Chief Financial Officer2025-12-03461$2.15
$992.53Sell
Gilmore Neil OneillCEO2025-09-035,592$2.60
$14.52kSell
Amy ParisonSVP Chief Financial Officer2025-09-03458$2.60
$1.19kSell
Linda BurklyEVP CHIEF SCIENTIFIC OFFICER2025-09-03710$2.60
$1.84kSell
Amy ParisonSVP Chief Financial Officer2025-08-07679$2.58
$1.75kSell

1 of 2

EDIT insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when EDIT insiders and whales buy or sell their stock.

EDIT Shareholders

What type of owners hold Editas Medicine Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc9.55%9,347,114$21.87MInstitution
Vanguard Group Inc8.39%8,208,068$19.21MInstitution
Third Rock Ventures III LP3.99%3,906,176$9.14MInsider
Kevin P. Starr3.99%3,906,176$9.14MInsider
Polaris Venture Management Co VI LLC3.88%3,797,144$8.89MInsider
Renaissance Technologies LLC3.11%3,039,778$7.11MInstitution
Viking Global Investors LP3.06%2,996,590$7.01MInsider
Kevin Bitterman2.86%2,797,144$6.55MInsider
Flagship Ventures Fund IV LP2.85%2,786,967$6.52MInsider
Boris Nikolic2.74%2,684,572$6.28MInsider

1 of 3

EDIT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
EDIT51.02%33.67%Net SellingNet Selling
VYGR53.27%46.73%Net SellingNet Selling
CHRS34.23%14.29%Net SellingNet Selling
HELP60.30%0.00%
ALEC64.04%35.96%Net SellingNet Selling
View Top Biotech Stocks

Editas Medicine Stock Ownership FAQ

Who owns Editas Medicine?

Editas Medicine (NASDAQ: EDIT) is owned by 51.02% institutional shareholders, 33.67% Editas Medicine insiders, and 15.31% retail investors. Third Rock Ventures III LP is the largest individual Editas Medicine shareholder, owning 3.91M shares representing 3.99% of the company. Third Rock Ventures III LP's Editas Medicine shares are currently valued at $9.14M.

If you're new to stock investing, here's how to buy Editas Medicine stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.